Ascent Wealth Partners’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,279	Closed	-$831K	–	120
2019 Q3	$831K	Buy	6,279 +200	+3%	+$26.8K	0.25%	66
2019 Q2	$863K	Buy	6,079 +260	+4%	+$35.3K	0.27%	67
2019 Q1	$845K	Buy	5,819 +451	+8%	+$59.3K	0.28%	66
2018 Q4	$608K	Sell	5,368 -40	-0.7%	-$5.01K	0.24%	74
2018 Q3	$728K	Buy	5,408 +111	+2%	+$13.7K	0.23%	81
2018 Q2	$594K	Buy	5,297 +29	+0.6%	+$3.13K	0.21%	82
2018 Q1	$562K	Buy	5,268 +30	+0.6%	+$3.23K	0.2%	84
2017 Q4	$573K	Buy	5,238 +8	+0.2%	+$871	0.21%	83
2017 Q3	$565K	Buy	5,230 +160	+3%	+$16.4K	0.23%	79
2017 Q2	$513K	Sell	5,070 -5	-0.1%	-$460	0.22%	82
2017 Q1	$456K	Buy	5,075 +25	+0.5%	+$2.12K	0.21%	82
2016 Q4	$385K	Buy	+5,050	New	+$384K	0.19%	88